COCCO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 507
EU - Europa 419
AS - Asia 294
SA - Sud America 29
AF - Africa 2
Totale 1.251
Nazione #
US - Stati Uniti d'America 501
GB - Regno Unito 140
CN - Cina 137
SG - Singapore 100
RU - Federazione Russa 93
SE - Svezia 53
FR - Francia 30
HK - Hong Kong 28
BR - Brasile 26
DE - Germania 26
IE - Irlanda 25
FI - Finlandia 19
IT - Italia 13
KR - Corea 9
UA - Ucraina 7
VN - Vietnam 5
BD - Bangladesh 4
CA - Canada 4
BE - Belgio 3
IN - India 3
JP - Giappone 3
AT - Austria 2
ES - Italia 2
PL - Polonia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
CH - Svizzera 1
CO - Colombia 1
EC - Ecuador 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
MZ - Mozambico 1
NL - Olanda 1
PA - Panama 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 1.251
Città #
Southend 108
Chandler 83
Jacksonville 56
Singapore 49
Houston 47
Ann Arbor 35
Ashburn 32
Dallas 29
Beijing 28
Hong Kong 28
Moscow 26
Dublin 25
Woodbridge 25
Lancaster 12
Lawrence 11
Princeton 11
Jinan 9
Nanjing 9
Seoul 9
Wilmington 9
Columbus 7
Hebei 7
Helsinki 7
Redondo Beach 7
Boardman 6
Detroit 6
Munich 6
Nanchang 6
New York 6
Santa Clara 6
Tianjin 6
Jiaxing 5
Verona 5
Atlanta 4
Buffalo 4
São Paulo 4
Taiyuan 4
Brussels 3
Cascia 3
Dearborn 3
Guangzhou 3
Leipzig 3
Los Angeles 3
Phoenix 3
Rio de Janeiro 3
Tokyo 3
Zhengzhou 3
Brooklyn 2
Chennai 2
Chicago 2
Falkenstein 2
Fuzhou 2
Haikou 2
Hangzhou 2
Hanoi 2
Ho Chi Minh City 2
London 2
Naples 2
North Bergen 2
Nuremberg 2
Poplar 2
Seattle 2
Shenyang 2
The Dalles 2
Toronto 2
Amman 1
Anápolis 1
Aquiraz 1
Auburn Hills 1
Augusta 1
Bilgi 1
Boston 1
Burgas 1
Bình An 1
Calgary 1
Cambé 1
Changsha 1
Chaoyang 1
City of London 1
Clearwater 1
Cleveland 1
Colatina 1
Cormons 1
Cotia 1
Council Bluffs 1
Cuddalore 1
Curitiba 1
Denver 1
Dhaka 1
Dubai 1
Edinburgh 1
Elk Grove Village 1
Esteio 1
Fairfield 1
Frankfurt am Main 1
Fushan 1
Hyattsville 1
Iaciara 1
Istanbul 1
Johannesburg 1
Totale 838
Nome #
Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis of Prostate Cancer and Subsequent Cluster Selection of the Patient Population Undergoing Standard Radical Prostatectomy 148
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 127
Investigative clinical study on prostate cancer part VIII: prolactin hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy. 123
Investigative clinical study on prostate cancer Part V: Luteinizing hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. 119
Investigative clinical study on prostate cancer part VI: Follicle-stimulating hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. 118
Choosing wisely: la lista del gruppo di studio Endocrinologia e Malattie del Metabolismo della Società Italiana di Patologia Clinica e Medicina di Laboratorio 115
Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy 108
DEFINITION OF UPPER REFERENCE LIMIT FOR THYROID PEROXIDASE AUTOANTIBODIES ACCORDING TO NACB GUIDELINES: COMPARISON OF SEVEN DIFFERENT AUTOMATED METHODS. Part B (in : Reference ranges, standardization and decision levels) 106
Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. 102
DEFINITION OF UPPER REFERENCE LIMIT FOR THYROID PEROXIDASE AUTOANTIBODIES ACCORDING TO NACB GUIDELINES: COMPARISON OF FIVE DIFFERENT AUTOMATED METHODS. PART A (in Reference ranges, standardization and decision levels) 101
Role of CA 15-3 to guide therapy in metastatic breast cancer [Il ruolo di CA 15-3 nel monitoraggio della terapia nel carcinoma mammario metastatico] 97
Totale 1.264
Categoria #
all - tutte 4.890
article - articoli 4.090
book - libri 0
conference - conferenze 800
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 6 10 2 5 0 1 9 3
2021/2022118 12 36 0 23 0 7 2 6 2 2 4 24
2022/2023196 20 17 23 26 20 41 3 17 16 1 8 4
2023/202497 4 14 9 5 16 15 1 7 0 11 10 5
2024/2025194 9 18 15 33 5 13 2 4 24 11 18 42
2025/2026252 54 23 40 116 19 0 0 0 0 0 0 0
Totale 1.264